A research investigation by Xu et al. documented that glaucocalyxin B has a mitigating effect on PD caused by LPS through the suppression of the TLR/NF-κB pathway and stimulation of the HO-1/Nrf2 pathway. Here, NFKB1 is linked to Parkinson disease.